A case of the drug-induced hepatic injury by Nyoshin-san^® and Saffron-K^®

Abstract

A 55-year-old woman was hospitalized because of general fatigue, jaundice and the elevation of serum hepatic and biliary enzymes. She was suffering from menopausal disorders, and had undergone treatment with oral administration of Nyoshin-san^® and the Saffron-K^® for 3 months before admission. Liver injury related to Nyoshin-san^® and the Saffron-K^® was suspected, and the medication was stopped. After cessation of the medication, she recovered from her illness, and the elevated enzymes gradually declined. According to the diagnostic scale for drug-induced hepatic injury at the workshop in Digestive Disease Week-Japan 2004, her liver injury was classified into hepatocellular type and judged "highly possible". These drugs were positive in drug-lymphocyte stimulation test (DLST). Liver biopsy showed the inflammatory infiltrate with eosinophils and slight fibrosis in the portal areas. We hereunder report our experiences on this rare case of drug-induced hepatic injury by Nyoshin-san^® and Saffron-K^®.
We reported of the drug-induced hepatic injury by Nyoshin-san and Saffron-K. Our reports experience with a rare case.